SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008882
Filing Date
2017-11-14
Accepted
2017-11-14 07:38:52
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20170930x10q.htm 10-Q 1866909
2 EX-10.10 rytm-20170930ex1010f9b7e.htm EX-10.10 183757
3 EX-10.2 rytm-20170930ex102a02cce.htm EX-10.2 325463
4 EX-31.1 rytm-20170930ex311af5a86.htm EX-31.1 15714
5 EX-31.2 rytm-20170930ex3128ba82a.htm EX-31.2 14903
6 EX-32.1 rytm-20170930ex3212b11ac.htm EX-32.1 8443
7 EX-32.2 rytm-20170930ex3225e28fc.htm EX-32.2 8432
  Complete submission text file 0001558370-17-008882.txt   5563943

Data Files

Seq Description Document Type Size
8 EX-101.INS rytm-20170930.xml EX-101.INS 855595
9 EX-101.SCH rytm-20170930.xsd EX-101.SCH 32015
10 EX-101.CAL rytm-20170930_cal.xml EX-101.CAL 31343
11 EX-101.DEF rytm-20170930_def.xml EX-101.DEF 127808
12 EX-101.LAB rytm-20170930_lab.xml EX-101.LAB 303575
13 EX-101.PRE rytm-20170930_pre.xml EX-101.PRE 226188
Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

IRS No.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 171198335
SIC: 2834 Pharmaceutical Preparations